Recent Blog Articles
Masks save lives: Here’s what you need to know
Stretching studios: Do you need what they offer?
Why are women more likely to develop Alzheimer’s disease?
Seeing red? 4 steps to try before responding
Tics and TikTok: Can social media trigger illness?
Pandemic challenges may affect babies — possibly in long-lasting ways
4 immune-boosting strategies that count right now
If you have knee pain, telehealth may help
How to address opposition in young children
New study investigates treatment-associated regrets in prostate cancer
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Men's Health
New study investigates treatment-associated regrets in prostate cancer
Men's Health
Acupuncture relieves prostatitis symptoms in study
Men's Health
Recent study shows more complications with alternative prostate biopsy method
Men's Health
Study: No effect on cognitive functioning from treatments for advanced prostate cancer
Men's Health
Cardiovascular safety from prostate cancer drugs remains uncertain
Men's Health
Level of health literacy affects treatment choice for slow-growing prostate cancer
Men's Health
A new treatment for advanced prostate cancer improves survival in phase 3 clinical trial
Men's Health
Large review study finds low risk of erectile dysfunction after prostate biopsy
Men's Health
American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer
Charlie Schmidt
An emerging treatment option for men with recurring prostate cancer after radiation therapy
Charlie Schmidt
Improving PET scans are good news for doctors and patients alike
Charlie Schmidt
Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures
Charlie Schmidt
New high-resolution imaging scans approved for use in prostate cancer
Charlie Schmidt
The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer
Charlie Schmidt
New online model identifies which men can have fewer biopsies on active surveillance
Charlie Schmidt
Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Charlie Schmidt
Hormonal treatments for prostate cancer are often given late
Charlie Schmidt
A new hormonal therapy for prostate cancer is under expedited FDA review
Charlie Schmidt
New drugs approved for advanced BRCA-positive prostate cancer
Charlie Schmidt
Combining different biopsies limits uncertainty in prostate cancer diagnosis
Charlie Schmidt
New radiation therapies keep advanced prostate cancer in check
Charlie Schmidt
New study compares long-term side effects from different prostate cancer treatments
Charlie Schmidt
African American and white men who receive comparable treatments for prostate cancer have similar survival
Charlie Schmidt
